Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma
A Grigg, Janey Stone, Alvin Milner, A Schwarer, Max Wolf, H Prince, John Seymour, Devinder Gill, David Ellis, John Bashford
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma'. Together they form a unique fingerprint.